TERRI TROMBLEY: Open Payments
NPI 1609312420 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 18 payments from 10 companies in 2025. Trend: 2023 $154 · 2024 $199 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 1 | $110 |
| Travere Therapeutics, Inc. | 4 | $63 |
| Calliditas Therapeutics US Inc. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Fresenius USA Marketing, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
| AKEBIA THERAPEUTICS INC | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $21 |
Products named: TERLIVAZ, TARPEYO, JARDIANCE, Kerendia, VELPHORO, BENLYSTA, Empaveli, Vafseo.
Industry payments across MI — which companies pay providers there.
